Meta's Record-Breaking Share Price Rally Boosts Options Volume After TikTok Ban Law Upheld
Fed Officials Flag Inflation Concerns Ahead of Meeting on Rates
Tesla CEO Elon Musk Reveals Reason Behind Dropping Company Logo On Cybercab: 'If The Product Is Special Enough...'
Wall Street's bullish research reports for US stocks are becoming increasingly aggressive! Oppenheimer has given the "wildest outlook": the s&p 500 will reach 7100 points next year.
Oppenheimer, with a target of 7,100 points, has become the most bullish institution on the s&p 500 index; Wall Street is optimistic about the performance of the usa stock market in 2025.
Google Payment Placed Under CFPB Supervision, Company Hits Back With Lawsuit
Stocks And Crypto Ride Optimism, But November CPI Could Be The Ultimate Market Test, Investors Warn
The Stock Market's Earnings Estimates Are Falling. That Could Become a Problem
Searching for the Top AI Stocks of 2025
Tesla Stock Hits $400 In Overnight Trading On Robinhood Amid Analyst Upgrades And FSD Optimism
Elon Musk Asks 'Was It Ever Not A Lie' As OpenAI Plans To Drop AGI Clause In Microsoft Deal
Palantir's Shyam Sankar Says AI The New Frontier In Defense — Reflects On Possible Pentagon Rule Under Trump As Stock Soars
Will the U.S. stock market rise at least 5% next year? Wall Street's major firms have released their year-end forecasts: everyone is call!
Wall Street's outlook for the stock market in 2025.
Amazon Shareholders Propose Adding Bitcoin To Treasury For 'Best' Long-Term Interest, Cite Michael Saylor's MicroStrategy As Example
Musk-Altman Rivalry Intensifies With Trump's Appointment of David Sacks
Apple Faces $1.2B Lawsuit Over Child Sexual Abuse Material Detection On ICloud — Tech Giant Says, 'Urgently And Actively Innovating'
What to Expect in the Week Ahead (ADBE, AVGO, COST Earnings; US November CPI)
Stock Futures Are Little Changed After S&P 500 Posts Third-straight Winning Week
Apple Eyes Sony Partnership For Game-Changing Vision Pro Upgrade
Trump Team Contacts Google, Meta, Snap Over Online Drug Sales: Report
Stocks With Best Odds of Risk-adjusted Returns Deserve Attention: Goldman Sachs